Literature DB >> 16729674

Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture.

Kazuhiko Nishimura1, Takako Yanase, Noriko Araki, Yoshihiro Ohnishi, Shunji Kozaki, Kensuke Shima, Masahiro Asakura, Worada Samosomsuk, Shinji Yamasaki.   

Abstract

We studied the effects of polyamines, which are necessary for proliferation and antioxidation in Trypanosoma brucei gambiense Wellcome strain (WS) and Trypanosoma brucei brucei ILtat 1.4 strain (IL). No difference was found in activity of ornithine decarboxylase (ODC), a key enzyme in polyamine synthesis in trypanosomes, in both strains maintained in vitro; higher (P < 0.05) ODC values were found in IL in vivo. However, WS in vivo exhibited higher proliferation rates with higher spermidine content and decreased host survival times than IL. The in vitro proliferation and polyamine contents of WS increased with the addition of polyamine to the 1-difluoromethylornithine culture medium, but not IL. These results suggested that WS uses extracellular polyamine for proliferation. In the in vitro culture, WS was less tolerant of hydrogen peroxide (oxidative stress) than IL, and malondialdehyde levels in WS were higher than in IL. The expression of trypanothione synthetase mRNA in WS in vitro was higher than in IL. These results suggest that IL is dependent on the synthesis of polyamines for proliferation and reduction of oxidative stress, whereas WS is dependent on the uptake of extracellular polyamines. A thorough understanding of the differences in the metabolic capabilities of various trypanosomes is important for the design of more effective medical treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729674     DOI: 10.1645/GE-633R.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.

Authors:  Robert H Barker; Hanlan Liu; Bradford Hirth; Cassandra A Celatka; Richard Fitzpatrick; Yibin Xiang; Erin K Willert; Margaret A Phillips; Marcel Kaiser; Cyrus J Bacchi; Aixa Rodriguez; Nigel Yarlett; Jeffrey D Klinger; Edmund Sybertz
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

Review 2.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

3.  A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity.

Authors:  Géraldine De Muylder; Sylvie Daulouède; Laurence Lecordier; Pierrick Uzureau; Yannick Morias; Jan Van Den Abbeele; Guy Caljon; Michel Hérin; Philippe Holzmuller; Silla Semballa; Pierrette Courtois; Luc Vanhamme; Benoît Stijlemans; Patrick De Baetselier; Michael P Barrett; Jillian L Barlow; Andrew N J McKenzie; Luke Barron; Thomas A Wynn; Alain Beschin; Philippe Vincendeau; Etienne Pays
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.